SunTrust Banks set a $40.00 target price on Envision Healthcare (NYSE:EVHC) in a report released on Thursday. The brokerage currently has a buy rating on the stock.

A number of other equities research analysts have also weighed in on EVHC. Jefferies Group set a $41.00 price objective on shares of Envision Healthcare and gave the company a buy rating in a report on Tuesday, December 19th. Piper Jaffray Companies began coverage on shares of Envision Healthcare in a research note on Wednesday, December 13th. They set a neutral rating and a $35.00 price target on the stock. KeyCorp cut their price target on shares of Envision Healthcare from $67.00 to $37.00 and set an overweight rating on the stock in a research note on Thursday, November 2nd. Robert W. Baird reiterated a buy rating and set a $70.00 price target on shares of Envision Healthcare in a research note on Tuesday, October 17th. Finally, Mizuho set a $57.00 price target on shares of Envision Healthcare and gave the stock a hold rating in a research note on Tuesday, October 31st. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. Envision Healthcare presently has a consensus rating of Buy and an average price target of $43.25.

Envision Healthcare (EVHC) opened at $34.38 on Thursday. The firm has a market cap of $4,180.00, a P/E ratio of -23.07, a P/E/G ratio of 1.16 and a beta of 0.57. Envision Healthcare has a 1 year low of $23.77 and a 1 year high of $73.00. The company has a current ratio of 3.01, a quick ratio of 3.00 and a debt-to-equity ratio of 0.89.

Envision Healthcare (NYSE:EVHC) last released its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.08). The business had revenue of $1.99 billion for the quarter, compared to analyst estimates of $2.03 billion. Envision Healthcare had a positive return on equity of 4.88% and a negative net margin of 6.39%. Envision Healthcare’s quarterly revenue was up 142.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.13 earnings per share. analysts expect that Envision Healthcare will post 2.49 earnings per share for the current fiscal year.

Envision Healthcare announced that its Board of Directors has authorized a stock buyback plan on Monday, September 18th that permits the company to repurchase $250.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 4.5% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.

A number of hedge funds have recently added to or reduced their stakes in the stock. Sawtooth Solutions LLC raised its position in shares of Envision Healthcare by 0.7% in the second quarter. Sawtooth Solutions LLC now owns 6,656 shares of the company’s stock valued at $417,000 after buying an additional 43 shares during the last quarter. Boys Arnold & Co. Inc. raised its position in shares of Envision Healthcare by 0.6% in the second quarter. Boys Arnold & Co. Inc. now owns 8,125 shares of the company’s stock valued at $509,000 after buying an additional 50 shares during the last quarter. PNC Financial Services Group Inc. raised its position in shares of Envision Healthcare by 1.5% in the second quarter. PNC Financial Services Group Inc. now owns 4,848 shares of the company’s stock valued at $304,000 after buying an additional 70 shares during the last quarter. Utah Retirement Systems raised its position in shares of Envision Healthcare by 0.5% in the second quarter. Utah Retirement Systems now owns 21,289 shares of the company’s stock valued at $1,335,000 after buying an additional 100 shares during the last quarter. Finally, M&T Bank Corp raised its position in shares of Envision Healthcare by 2.7% in the second quarter. M&T Bank Corp now owns 5,420 shares of the company’s stock valued at $341,000 after buying an additional 141 shares during the last quarter.

ILLEGAL ACTIVITY NOTICE: “Envision Healthcare (EVHC) PT Set at $40.00 by SunTrust Banks” was originally posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark law. The legal version of this piece of content can be accessed at https://theolympiareport.com/2017/12/25/envision-healthcare-evhc-pt-set-at-40-00-by-suntrust-banks.html.

About Envision Healthcare

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.